Role of Chk1 in the differentiation program of hematopoietic stem cells

Research output: Contribution to journalArticlepeer-review


Hematopoietic stem cells (HSC) isolated from umbilical cord blood (UCB) were treated with ionizing radiation (IR) and sensitivity and IR induced checkpoints activation were investigated. No difference in the sensitivity and in the activation of DNA damage pathways was observed between CD133+ HSC and cells derived from them after ex vivo expansion. Chk1 protein was very low in freshly isolated CD133+ cells, and undetectable in ex vivo expanded UCB CD133+ cells. Chk1 was expressed only on day 3 of the ex vivo expansion. This pattern of Chk1 expression was corroborated in CD133+ cells isolated from peripheral blood apheresis collected from an healthy donor. Treatment with a specific Chk1 inhibitor resulted in a strong reduction in the percentage of myeloid precursors (CD33+) and an increase in the percentage of lymphoid precursors (CD38+) compared to untreated cells, suggesting a possible role for Chk1 in the differentiation program of UCB CD133+ HSC.

Original languageEnglish
Pages (from-to)1713-1722
Number of pages10
JournalCellular and Molecular Life Sciences
Issue number10
Publication statusPublished - May 2010


  • Chk1
  • Differentiation
  • DNA damage
  • Stem and progenitor cells
  • Umbilical cord blood

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Medicine(all)
  • Cellular and Molecular Neuroscience
  • Pharmacology

Fingerprint Dive into the research topics of 'Role of Chk1 in the differentiation program of hematopoietic stem cells'. Together they form a unique fingerprint.

Cite this